News

Michael Shen, PhD, the Arthur J. Antenucci Professor of Medical Sciences and  professor of genetics, urology, and systems biology at Columbia’s Vagelos College of Physicians and Surgeons, has been named a fellow of the American Association for the Advancement of Science (AAAS)(link is external and opens in a new window). Dr. Shen, who also co-leads the Tumor Biology and Microenvironment research program at the Herbert Irving Comprehensive Cancer Center (HICCC), joins four other Columbia faculty members who have been elected to the 2021 class of AAAS fellows.

Read full article on Herbert Irving Comprehensive Cancer Center News Page

 

A discussion with Andrea Califano(link is external and opens in a new window) and narrative medicine writer Rita Charon, "Aflight in ideas and visions, he and his colleagues in systems biology have been soaring toward what Califano predicts as the Golden Age of Biology. Not unlike the golden ages of physics and chemistry, when Newton and Lavoisier broke through conceptual barriers to see with new minds, this age equips biology for flight"

Read full article on Narratives of Discovery page.

December 14, 2021

New award for Chaolin Zhang

Chaolin Zhang, PhD, Associate Professor in Systems Biology will receive $2,766,392 over five years from the National Insititue of Neurological Disorders and Stroke for “RNA regulatory networks in neuronal cell type diversity and function”. This award will support Dr. Zhang to understand better post-transcriptional gene expression regulation through specific protein -RNA interactions, or RNA-regulatory networks which is critical for expanding the complexity of the mammalian nervous system with implications in an expanding list of neuronal disorders. The proposed studies will investigate alternative splicing regulation in generating the distinct molecular programs in diverse neuronal cell types of mouse cortex. Information obtained in this project will provide insights into the fundamental mechanisms that controls such diversity as well as the functional consequences in defined, clinically relevant neuronal cell types.

Chaolin Zhang, PhD, Associate Professor in Systems Biology will receive $1,200,000 over three years from The Simons Foundation Autism Research Initiative (SFARI) via the 2021 Genomics of ASD: Pathways to Genetic Therapies Initiative.  Grants funded through this Initiative are intended to leverage current knowledge about risk genes for autism spectrum disorder (ASD) into the development of new genetic therapies.  Leveraging the target discovery platform developed by the lab, Dr. Zhang’s research goal on this project focuses on restoring functional protein production using antisense oligos (ASOs) by modulating the alternative splicing as potential therapeutics. 

Read full article on Simons Foundation website.